Patents by Inventor Raymond Playford

Raymond Playford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060198900
    Abstract: A method for prophylactically treating a gastrointestinal disorder or skin ailment in a mammal through the administration of an enhanced bioactive agent composition comprising a bioactive agent and at least one of a soy product, licorice product, or sodium bicarbonate (depending upon the indication to be treated) is provided according to the invention. The bioactive agent preferably is bovine colostrum. The effective amount of enhanced bioactive agent composition to be used will depend upon such factors as the age and weight of the mammal, the bioactivity level of the bioactive agent, the gastrointestinal disorder or skin ailment at issue, and whether treatment of existing symptoms of the gastrointestinal disorder or skin ailment, or prevention of the onset of such symptoms is desired. A medicament comprising an enhanced bioactive agent composition for prophylactically treating a gastrointestinal disorder or skin ailment in a mammal is also provided according to the invention.
    Type: Application
    Filed: May 18, 2006
    Publication date: September 7, 2006
    Applicant: Nutritional Bioscience Limited
    Inventor: Raymond Playford
  • Publication number: 20060069513
    Abstract: A method of scoring the biological activity of bioactive agents like colostrum comprising conducting separate bioassays for cell restitution and cell proliferation on the bioactive agent, a comparative growth factor stimulating agent, and (preferably) a negative baseline control sample containing the cells and growth medium alone. These values are then plugged into the equations provided in this application to calculate a Restitution Score (“RS”), Proliferation Score (“PS”), and a composite repair and protection factor score (“RPF”). In this manner, the bioactivity of compositions that enhance the repair and/or proliferation of mammalian cells, or act as additives to growth media used to maintain and grow laboratory cell cultures can be quickly and reproducibly obtained. This invention may be applied to a wide variety of bioactive agents used to treat a large assortment of functional cells in organ tissues.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 30, 2006
    Inventor: Raymond Playford
  • Publication number: 20060068022
    Abstract: A method for prophylactically treating a gastrointestinal disorder or skin ailment in a mammal through the administration of an enhanced bioactive agent composition comprising a bioactive agent and at least one of a soy product, licorice product, or sodium bicarbonate (depending upon the indication to be treated) is provided according to the invention. The bioactive agent preferably is bovine colostrum. The effective amount of enhanced bioactive agent composition to be used will depend upon such factors as the age and weight of the mammal, the bioactivity level of the bioactive agent, the gastrointestinal disorder or skin ailment at issue, and whether treatment of existing symptoms of the gastrointestinal disorder or skin ailment, or prevention of the onset of such symptoms is desired. A medicament comprising an enhanced bioactive agent composition for prophylactically treating a gastrointestinal disorder or skin ailment in a mammal is also provided according to the invention.
    Type: Application
    Filed: September 29, 2004
    Publication date: March 30, 2006
    Inventor: Raymond Playford
  • Publication number: 20060013889
    Abstract: A method for prophylactically treating irritable bowel syndrome in a mammal through the administration of a colostral composition like bovine colostrum is provided, although other forms of colostrum or other components exhibiting colostrum activity like lactoferrin, casein, or whey may be used. The effective amount of colostral composition to be used will depend upon such factors as the age and weight of the mammal, the bioactivity level of the colostral composition, and whether treatment of existing IBS symptoms, or prevention of the onset of IBS symptoms is desired. A medicament comprising such a colostral composition for prophylactically treating IBS in a mammal is also provided.
    Type: Application
    Filed: July 16, 2004
    Publication date: January 19, 2006
    Inventors: Raymond Playford, Randall Kjelden